The University of Southampton
University of Southampton Institutional Repository

Chapter 10 - Antibody glycosylation

Chapter 10 - Antibody glycosylation
Chapter 10 - Antibody glycosylation

The antibody Fc region is posttranslationally modified by N-linked glycosylation. In immunoglobulin G (IgG), the processing of the glycans is restricted by the presence of extensive interaction with the protein surface. The resulting set of antibody glycoforms exhibit a range of effector functions. In this chapter, we outline the impact of glycosylation on the immune function of antibodies and discuss the implications for monoclonal antibody and intravenous immunoglobulin therapies.

Antiboday glycosylation, Antiinflammatory signaling, Degree of flexibility, Glycan biogenesis, Glycan-engineered antibodies, Inflamatory activity, Terminal galactosylation, Terminal mannose, Terminal sialylation
179-194
Elsevier Inc.
Yu, Xiaojie
44d52374-eacc-4e23-b7da-c881e6d3a5dd
Baruah, Kavitha
a02f59f3-5e0f-4735-9fdd-639bdbb8f563
Scanlan, Christopher N.
04dd1b57-b6fc-414c-8595-08310dbb3d32
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Yu, Xiaojie
44d52374-eacc-4e23-b7da-c881e6d3a5dd
Baruah, Kavitha
a02f59f3-5e0f-4735-9fdd-639bdbb8f563
Scanlan, Christopher N.
04dd1b57-b6fc-414c-8595-08310dbb3d32
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9

Yu, Xiaojie, Baruah, Kavitha, Scanlan, Christopher N. and Crispin, Max (2013) Chapter 10 - Antibody glycosylation. In, Antibody Fc: Linking Adaptive and Innate Immunity. Elsevier Inc., pp. 179-194. (doi:10.1016/B978-0-12-394802-1.00010-8).

Record type: Book Section

Abstract

The antibody Fc region is posttranslationally modified by N-linked glycosylation. In immunoglobulin G (IgG), the processing of the glycans is restricted by the presence of extensive interaction with the protein surface. The resulting set of antibody glycoforms exhibit a range of effector functions. In this chapter, we outline the impact of glycosylation on the immune function of antibodies and discuss the implications for monoclonal antibody and intravenous immunoglobulin therapies.

This record has no associated files available for download.

More information

e-pub ahead of print date: 12 September 2013
Published date: 2013
Keywords: Antiboday glycosylation, Antiinflammatory signaling, Degree of flexibility, Glycan biogenesis, Glycan-engineered antibodies, Inflamatory activity, Terminal galactosylation, Terminal mannose, Terminal sialylation

Identifiers

Local EPrints ID: 414416
URI: http://eprints.soton.ac.uk/id/eprint/414416
PURE UUID: 1b817368-f2d1-4162-ab5c-19bab2dbf882
ORCID for Max Crispin: ORCID iD orcid.org/0000-0002-1072-2694

Catalogue record

Date deposited: 28 Sep 2017 16:31
Last modified: 06 Jun 2024 01:59

Export record

Altmetrics

Contributors

Author: Xiaojie Yu
Author: Kavitha Baruah
Author: Christopher N. Scanlan
Author: Max Crispin ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×